Richard Labelle - Net Worth and Insider Trading
Richard Labelle Net Worth
The estimated net worth of Richard Labelle is at least $33,432 dollars as of 2024-11-13. Richard Labelle is the Senior Officer of Medexus Pharmaceuticals Inc and owns about 17,057 shares of Medexus Pharmaceuticals Inc (TSX:MDP) stock worth over $33,432. Details can be seen in Richard Labelle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Labelle has not made any transactions after 2021-06-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard Labelle
Richard Labelle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard Labelle owns 1 companies in total, including Medexus Pharmaceuticals Inc (TSX:MDP) .
Click here to see the complete history of Richard Labelle’s form 4 insider trades.
Insider Ownership Summary of Richard Labelle
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:MDP | Medexus Pharmaceuticals Inc | 2021-06-21 | Senior Officer |
Richard Labelle Latest Holdings Summary
Richard Labelle currently owns a total of 1 stock. Richard Labelle owns 17,057 shares of Medexus Pharmaceuticals Inc (TSX:MDP) as of June 21, 2021, with a value of $33,432.
Latest Holdings of Richard Labelle
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:MDP | Medexus Pharmaceuticals Inc | 2021-06-21 | 17,057 | 1.96 | 33,432 |
Holding Weightings of Richard Labelle
Richard Labelle Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard Labelle has made a total of 1 transactions in Medexus Pharmaceuticals Inc (TSX:MDP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Medexus Pharmaceuticals Inc is the acquisition of 3,260 shares on June 21, 2021, which cost Richard Labelle around $23,472.
Insider Trading History of Richard Labelle
- 1
Richard Labelle Trading Performance
GuruFocus tracks the stock performance after each of Richard Labelle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard Labelle is -54.86%. GuruFocus also compares Richard Labelle's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard Labelle within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard Labelle's insider trading performs compared to the benchmark.
Performance of Richard Labelle
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.71 | | | | | |
| Relative Return to S&P 500(%) | 7.54 | | | | | |
Richard Labelle Ownership Network
Ownership Network List of Richard Labelle
Ownership Network Relation of Richard Labelle
Richard Labelle Owned Company Details
What does Medexus Pharmaceuticals Inc do?
Who are the key executives at Medexus Pharmaceuticals Inc?
Richard Labelle is the Senior Officer of Medexus Pharmaceuticals Inc. Other key executives at Medexus Pharmaceuticals Inc include Senior Officer Brendon Buschman , Director & Senior Officer Kenneth d'Entremont , and Senior Officer Marcel Pascal Konrad .
Medexus Pharmaceuticals Inc (TSX:MDP) Insider Trades Summary
Over the past 18 months, Richard Labelle made no insider transaction in Medexus Pharmaceuticals Inc (TSX:MDP). Other recent insider transactions involving Medexus Pharmaceuticals Inc (TSX:MDP) include a net purchase of 20,000 shares made by Brendon Buschman , a net purchase of 7,000 shares made by Mike Mueller , and a net purchase of 18,800 shares made by Kenneth d'Entremont .
In summary, during the past 3 months, insiders sold 0 shares of Medexus Pharmaceuticals Inc (TSX:MDP) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 0 shares of Medexus Pharmaceuticals Inc (TSX:MDP) were sold and 147,900 shares were bought by its insiders, resulting in a net purchase of 147,900 shares.
Medexus Pharmaceuticals Inc (TSX:MDP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Medexus Pharmaceuticals Inc Insider Transactions
Richard Labelle Mailing Address
Above is the net worth, insider trading, and ownership report for Richard Labelle. Currently GuruFocus does not have mailing address information for Richard Labelle.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
